<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2021-4408</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-4408</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>КЛИНИЧЕСКАЯ И ИССЛЕДОВАТЕЛЬСКАЯ МЕДИЦИНА</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL AND INVESTIGATIVE MEDICINE</subject></subj-group></article-categories><title-group><article-title>Сердечная недостаточность 2019. Информация из журналов национальных кардиологических обществ</article-title><trans-title-group xml:lang="en"><trans-title>Heart Failure 2019. Insights From the National Society of Cardiology Journals</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Gatzov</surname><given-names>P.</given-names></name><name name-style="western" xml:lang="en"><surname>Gatzov</surname><given-names>P.</given-names></name></name-alternatives><bio xml:lang="ru"><p>MD, PhD, DSc, FESC, Medical University of Pleven, 1, St. Kl. Ohridski Street, 5800 Pleven, Bulgaria.</p></bio><email xlink:type="simple">cardiojournal@yandex.ru</email></contrib></contrib-group><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>13</day><month>03</month><year>2021</year></pub-date><volume>26</volume><issue>2</issue><fpage>4408</fpage><lpage>4408</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Gatzov P., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Gatzov P.</copyright-holder><copyright-holder xml:lang="en">Gatzov P.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/4408">https://russjcardiol.elpub.ru/jour/article/view/4408</self-uri><abstract><p>Первичная публикация: Gatzov P, Monsuez J-J, Agoston G, et al. Heart Failure 2019. European Heart Journal. 2021;42(6):557-9. doi:10.1093/eurheartj/ehaa918.</p></abstract><trans-abstract xml:lang="en"/><kwd-group xml:lang="ru"><kwd>Сердечная недостаточность</kwd><kwd>2019</kwd><kwd>журналы национальных кардиологических обществ</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Badran HM, Elgharably MA, Faheem N. Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit. Egypt Heart J. 2019;71:167.</mixed-citation><mixed-citation xml:lang="en">Badran HM, Elgharably MA, Faheem N. Clinical characteristics and in-hospital outcome of heart failure in women: a single center registry from Egyptian cardiac care unit. Egypt Heart J. 2019;71:167.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Martínez Santos P, Bover Freire R, Esteban Fernández A, et al. In-hospital mortality and readmissions for heart failure in Spain. A Study of Index Episodes and 30-Day and 1-year Cardiac Readmissions. Rev Esp Cardiol (Engl Ed). 2019;72:998-1004.</mixed-citation><mixed-citation xml:lang="en">Martínez Santos P, Bover Freire R, Esteban Fernández A, et al. In-hospital mortality and readmissions for heart failure in Spain. A Study of Index Episodes and 30-Day and 1-year Cardiac Readmissions. Rev Esp Cardiol (Engl Ed). 2019;72:998-1004.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Tomova V, Alexandrovna M, Atanasova M, et al. The polymorphism RS10455872 at the lipoprotein (a) gene locus enhances the risk of aortic valve disease. Bulg Cardiol J. 2019;4:45-50.</mixed-citation><mixed-citation xml:lang="en">Tomova V, Alexandrovna M, Atanasova M, et al. The polymorphism RS10455872 at the lipoprotein (a) gene locus enhances the risk of aortic valve disease. Bulg Cardiol J. 2019;4:45-50.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Kaufmann CC, Hennenberg J, Bonderman D, et al. Transthyretin amyloidosis – update 2019. Austr J Kardiol. 2019;26:112-6.</mixed-citation><mixed-citation xml:lang="en">Kaufmann CC, Hennenberg J, Bonderman D, et al. Transthyretin amyloidosis – update 2019. Austr J Kardiol. 2019;26:112-6.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Vertes V, Nogradi A, Porpaczy A, et al. Left ventricular global longitudinal strain is impaired in systemic sclerosis and shows a significant correlation with the functional capacity of the patients. Cardiol Hung. 2019;49:12-6.</mixed-citation><mixed-citation xml:lang="en">Vertes V, Nogradi A, Porpaczy A, et al. Left ventricular global longitudinal strain is impaired in systemic sclerosis and shows a significant correlation with the functional capacity of the patients. Cardiol Hung. 2019;49:12-6.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Lelyavina TA, Sitnikova MY, Galenko VL, et al. The role of muscle tissue in the pathogenesis of chronic heart failure-the potential of exposure (FORMA study). Russ J Cardiol. 2019;2:58-65.</mixed-citation><mixed-citation xml:lang="en">Lelyavina TA, Sitnikova MY, Galenko VL, et al. The role of muscle tissue in the pathogenesis of chronic heart failure-the potential of exposure (FORMA study). Russ J Cardiol. 2019;2:58-65.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Vdovenko DV, Libis RA. Assessment of the functional state of left heart in patients with chronic heart failure with preserved ejection fraction. Russ J Cardiol. 2019;2:26-30.</mixed-citation><mixed-citation xml:lang="en">Vdovenko DV, Libis RA. Assessment of the functional state of left heart in patients with chronic heart failure with preserved ejection fraction. Russ J Cardiol. 2019;2:26-30.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Içen YK, Demirtas AO, Koc AS, et al. Liver stiffness value obtained with ElastPQ ultrasound increases with NYHA class in chronic heart failure patients and reduced ejection fraction. Turk Kardiyol Dern Ars. 2019;47:281-3.</mixed-citation><mixed-citation xml:lang="en">Içen YK, Demirtas AO, Koc AS, et al. Liver stiffness value obtained with ElastPQ ultrasound increases with NYHA class in chronic heart failure patients and reduced ejection fraction. Turk Kardiyol Dern Ars. 2019;47:281-3.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Öztürk S, Gürbuz AS, Kirma C. Relationship between SYNTAX score and myocardial viability in ischemic cardiomyopathy. Turk Kardiyol Dern Ars. 2019;47:350-6.</mixed-citation><mixed-citation xml:lang="en">Öztürk S, Gürbuz AS, Kirma C. Relationship between SYNTAX score and myocardial viability in ischemic cardiomyopathy. Turk Kardiyol Dern Ars. 2019;47:350-6.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Guedeney P, Huchet F, Manigold T, et al. Incidence of risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation. Arch Cardiovasc Dis. 2019;112:765-72.</mixed-citation><mixed-citation xml:lang="en">Guedeney P, Huchet F, Manigold T, et al. Incidence of risk factors for and impact of readmission for heart failure after successful transcatheter aortic valve implantation. Arch Cardiovasc Dis. 2019;112:765-72.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
